Compare Cassava Sciences Inc (FLNA) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $45.68. The key difference: Vanguard Global ex-US Real Estate Index Fd ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | VNQI | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | — |
52-Week High | $4.64 | $50.76 |
52-Week Low | $1.09 | $43.26 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $45.70, up 0.79% with a bullish technical signal from moving averages. The ETF provides international real estate diversification with 682 holdings across 30+ countries, featuring a low 0.12% expense ratio and 4.6% dividend yield. Recent analysis highlights its cost advantage over competitors like RWX (0.59% fee) and recovery potential as global real estate transactions are projected to grow over 10% in 2026.
The outlook remains constructive given VNQI's valuation at 11.9x P/E and 0.9x P/B, though total returns have lagged domestic peers. Key risks include currency exposure, international regulatory changes, and interest rate sensitivity. For investors seeking global real estate diversification with low costs, VNQI offers compelling value despite performance headwinds versus U.S.-focused alternatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Vanguard Global ex-US Real Estate Index Fd ETF
The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →
